Both in Pharmaceuticals
Ovid Therapeutics vs Crescent Biopharma
Over the past year OVID returned +73.9% and CBIO returned +5.7%; their daily moves had a correlation of 0.27.
OVID +73.9% CBIO +5.7%Growth of $1, one year, split-adjusted
| Metric | OVID | CBIO |
|---|---|---|
| Price | $2.40 | $13.06 |
| Market cap | $468.7M | $485.1M |
| Today | +0.42% | +1.16% |
| 1 month | +2.6% | −6.3% |
| 6 months | −15.2% | −27.8% |
| Year to date | +47.2% | +10.1% |
| 1 year | +72.7% | +2.4% |
| Revenue growth (YoY) | −88.3% | — |
| Gross margin | 100.0% | — |
| Net margin | −2047.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 296.1× | 40.8× |
| Net cash | $117.2M | $171.6M |
| Dividend yield | — | — |
| Volatility (60d) | 59.0% | 68.9% |
| Short % of float | 10.2% | 21.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).